ITAT overturns lower authorities, finds transactions with Celestial Biologicals market-driven & justifies appellant's financial dealings

The ITAT allowed the appeal, overturning the lower authorities' decisions. It found that the appellant's transactions with Celestial Biologicals Limited were market-driven and not intended to unduly benefit the related party. The ITAT concluded that the appellant's charitable nature and financial dealings were transparent and justified, noting that the AO's disallowance of depreciation and denial of exemption under Sections 11 & 12 were incorrect. The ITAT emphasized that the appellant followed applicable accounting standards and that the revenue from selling Fresh Frozen Plasma added to profit, ultimately ruling in favor of the appellant.

---

---

Issues Involved:

1. Denial of exemption under Sections 11 & 12 of the Act.
2. Disallowance of depreciation claimed.
3. Disallowance of net application of income by purchase of fixed assets.
4. Disallowance of business loss carry forward.
5. Alternative claims regarding partial exemption and computation of income.
6. Alleged breach of law and principles of natural justice by lower authorities.
7. Charging of interest under Section 234B/C/D.
8. Initiation of penalty proceedings under Section 271(1)(c).

Issue-wise Detailed Analysis:

1. Denial of Exemption under Sections 11 & 12:
The CIT(A) upheld the AO's decision that the appellant trust provided undue benefit to a concern under Section 13(3)(c), thus denying the exemption of Rs. 18,63,860/- claimed under Sections 11 & 12. The AO noted that the appellant supplied Fresh Frozen Plasma (FFP) to Celestial Biologicals Limited at a significantly lower rate compared to the rate charged to patients, questioning the charitable nature of the transactions. The AO concluded that the transactions were intended to benefit Celestial Biologicals Limited, a related party, and thus violated Section 13(1)(c)(ii), leading to the denial of exemption.

2. Disallowance of Depreciation:
The AO disallowed the depreciation of Rs. 43,99,739/- claimed by the appellant, arguing that allowing depreciation on assets whose capital expenditure had already been treated as application of funds would result in double deduction. The appellant failed to provide detailed working of depreciation as per the Income Tax Act, leading to its disallowance.

3. Disallowance of Net Application of Income by Purchase of Fixed Assets:
The AO disallowed the claim of Rs. 13,09,804/- for net application of income by purchase of fixed assets, treating the capital expenditure as non-allowable since the exemption under Section 11 was denied. The AO assessed the total income at Rs. 75,73,403/-.

4. Disallowance of Business Loss Carry Forward:
The AO disallowed the carry forward of business loss amounting to Rs. 8,23,58,027/-, stating that the deficit from earlier years was computed under Section 11 and did not represent business losses as per the Income Tax Act. The AO required the appellant to prepare the profit and loss account and balance sheet as per normal commercial parlance.

5. Alternative Claims:
The appellant contended that even if the transactions violated Section 13, the entire exemption under Section 11 should not be denied. Instead, the denial should be limited to the transactions in violation. Additionally, the appellant argued that if the exempt income is treated as taxable business income, appropriate directions should be issued for computing the income on commercial principles and allowing set-off of carried forward deficit.

6. Alleged Breach of Law and Principles of Natural Justice:
The appellant claimed that the lower authorities failed to properly appreciate the facts and ignored various submissions, explanations, and information provided, resulting in a breach of law and principles of natural justice.

7. Charging of Interest under Section 234B/C/D:
The CIT(A) confirmed the AO's action of charging interest under Sections 234B, 234C, and 234D of the Act.

8. Initiation of Penalty Proceedings under Section 271(1)(c):
The CIT(A) also upheld the AO's initiation of penalty proceedings under Section 271(1)(c) of the Act.

Conclusion:
The ITAT found that the authorities below failed to understand the costing and processing cycle of the appellant’s operations. The FFP was a by-product, and its sale added to revenue and profit. The ITAT noted that the appellant followed applicable accounting standards and that the AO's disallowance of depreciation and denial of deduction under Section 11 were incorrect. The ITAT observed that the transactions with Celestial Biologicals Limited were market-driven and not intended to benefit the related party unduly. The ITAT allowed the appeal, concluding that the appellant's charitable nature and financial dealings were transparent and justified.

---